Artivion
AORT
136 hedge funds and large institutions have $645M invested in Artivion in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 60 increasing their positions, 34 reducing their positions, and 16 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 34
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
0.85% more ownership
Funds ownership: 84.15% → 85% (+0.85%)
0% more funds holding
Funds holding: 136 → 136 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $673M → $645M (-$27.5M)
Top Buyers
| 1 |
RA
Royce & Associates
New York
|
+$12.1M |
| 2 |
PA
Perceptive Advisors
New York
|
+$6.06M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.91M |
| 4 |
Morgan Stanley
New York
|
+$5.38M |
| 5 |
BlackRock
New York
|
+$3.9M |
Top Sellers
AORT Hedge Fund Activity: Q2 2022 in Review
136 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Artivion (AORT) for Q2 2022, worth a combined $645M — down 4.1% from $673M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AORT positions and 16 closed out — a net gain of 3 holders — while 60 added to existing stakes and 34 trimmed.
The largest buyer was Royce & Associates, adding an estimated $12.1M. The largest seller was William Blair Investment Management, cutting an estimated $17.5M.
- 136 institutional investors held Artivion (AORT) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $645M of Artivion stock for Q2 2022, down 4.1% quarter-over-quarter.
- 19 funds opened new Artivion positions in Q2 2022 and 16 closed out, a net change of +3 holders.
- The largest Artivion buyer in Q2 2022 was Royce & Associates, an estimated $12.1M added.
- The largest Artivion seller in Q2 2022 was William Blair Investment Management, an estimated $17.5M sold.
Based on aggregated 13F filings for Q2 2022.